Oakworth Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$10.7M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$6.78M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$6.64M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$6.56M |
| 5 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$4.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$9.7M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.69M |
| 3 |
iShares US Healthcare ETF
IYH
|
+$1.44M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$825K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$736K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.08% |
| 2 | Financials | 4.74% |
| 3 | Communication Services | 4.3% |
| 4 | Consumer Staples | 3.13% |
| 5 | Healthcare | 2.21% |
Similar funds
Oakworth Capital's Q3 2021 Portfolio in Review
As of Q3 2021, Oakworth Capital held 615 positions worth $1.04B, up 3.2% from $1B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Oakworth Capital deployed $38M of net new capital in Q3 2021, opening 26 new positions and adding to 91 existing holdings. Its largest new stake was Vanguard Intermediate-Term Corporate Bond ETF: 52,253 shares worth $4.93M.
By sector, the portfolio is most concentrated in Technology at 9.1% of assets, down from 9.1% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street Consumer Staples Select Sector SPDR ETF, an estimated $9.7M trimmed.
- Oakworth Capital's largest Q3 2021 buy was Vanguard Intermediate-Term Corporate Bond ETF: 52,253 shares worth $4.93M.
- Oakworth Capital added most to State Street Industrial Select Sector SPDR ETF in Q3 2021, an estimated $10.7M increase.
- Oakworth Capital's biggest Q3 2021 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $9.7M.
- Oakworth Capital fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $825K.
- Oakworth Capital's ten largest holdings make up 67% of its $1.04B portfolio in Q3 2021.
- Oakworth Capital opened 26 new positions and closed 39 in Q3 2021.
- Oakworth Capital's portfolio value rose 3.2% quarter-over-quarter to $1.04B.
Based on Oakworth Capital's 13F filing for Q3 2021, filed 10 Nov 2021.